What is the treatment for hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hypoglycemia

For conscious patients with hypoglycemia (blood glucose ≤70 mg/dL), immediately administer 15-20g of oral glucose, recheck blood glucose after 15 minutes, and repeat treatment if hypoglycemia persists. 1, 2

Immediate Treatment Protocol for Conscious Patients

Pure glucose is the preferred first-line treatment because the glycemic response correlates better with glucose content than with total carbohydrate content. 3, 1 Glucose tablets or glucose solution are the most effective options. 1

Standard Dosing Algorithm:

  • Adults and children >25 kg (or ≥6 years): Administer 15-20g of glucose orally 3, 1, 2
  • Children <25 kg (or <6 years): Administer 0.5 mg glucagon subcutaneously/intramuscularly 4
  • Patients on automated insulin delivery systems: Consider lower dose of 5-10g carbohydrates unless hypoglycemia occurs with exercise or after significant insulin overestimation 1, 5

Follow-Up Protocol:

  • Initial response should occur within 10-20 minutes 3, 1
  • Recheck blood glucose 15 minutes after treatment 3, 1, 2
  • If hypoglycemia persists, repeat with another 15-20g of carbohydrate 3, 1, 2
  • Evaluate blood glucose again at 60 minutes as additional treatment may be necessary 3, 1
  • Once blood glucose normalizes, provide a meal or snack with complex carbohydrates and protein to prevent recurrence 2, 5

Treatment Options and Effectiveness

While any carbohydrate-containing food with glucose can be used 3, 1, glucose tablets or solution are superior to orange juice or glucose gel for rapid symptom relief. 1 The glucose content of 10g can raise blood glucose by approximately 40 mg/dL over 30 minutes, while 20g raises it by 60 mg/dL over 45 minutes. 3

Important Considerations:

  • Adding fat to treatment slows and prolongs the glycemic response and should be avoided during acute treatment 3, 1
  • Protein should NOT be used to treat hypoglycemia as it may increase insulin secretion without providing adequate glucose 1, 5
  • Adding protein to carbohydrate treatment does not prevent subsequent hypoglycemia 3

Treatment for Severe Hypoglycemia (Unconscious Patients)

For patients unable or unwilling to consume oral carbohydrates, glucagon is indicated. 1, 2, 5

Glucagon Administration:

  • Adults and children >25 kg (or ≥6 years): 1 mg (1 mL) subcutaneously, intramuscularly, or intravenously 4
  • Children <25 kg (or <6 years): 0.5 mg (0.5 mL) subcutaneously, intramuscularly, or intravenously 4
  • If no response after 15 minutes, administer an additional dose using a new kit while waiting for emergency assistance 4
  • Call for emergency assistance immediately after administering glucagon 4

Newer intranasal and ready-to-inject glucagon preparations are now preferred due to ease of administration and better compliance. 1, 6 These formulations do not require reconstitution, making them more practical for emergency use. 6

Post-Glucagon Care:

  • When the patient responds and can swallow, give oral carbohydrates to restore liver glycogen and prevent recurrence 4
  • Sustained carbohydrate intake and observation are necessary because hypoglycemia may recur after apparent clinical recovery 7

Special Populations and Risk Factors

High-risk patients include those with advanced age (>60 years), history of hypoglycemia unawareness, prior severe hypoglycemia episodes, and those on insulin or sulfonylureas. 2

Pediatric Considerations:

  • Young children with type 1 diabetes are particularly vulnerable due to reduced ability to recognize symptoms 5
  • Prolonged and recurrent severe hypoglycemia in younger children can cause permanent neuropsychological dysfunction including learning disabilities 8

Medication-Related Causes:

  • Insulin and sulfonylureas are the most common medication-related causes 2, 5
  • Sulfonylureas have the highest risk among oral agents 2
  • Alpha-glucosidase inhibitors require treatment with monosaccharides (glucose tablets) as they prevent digestion of polysaccharides 3

Prevention Strategies

All patients at risk should have access to glucose tablets or glucose-containing foods at all times. 1, 2

Key Prevention Measures:

  • Avoid targeting overly tight glucose control; maintain blood glucose >70 mg/dL 1
  • For patients with hypoglycemia unawareness, raise glycemic targets for several weeks to reverse unawareness and reduce future risk 2
  • Educate patients about high-risk situations: fasting for tests, delayed meals, exercise, sleep, and alcohol consumption 2, 5
  • Coordinate medication administration with meal timing 2
  • Consider continuous glucose monitoring for those with recurrent hypoglycemia 5, 6

Family and Caregiver Education:

  • All family members and caregivers should be instructed on glucagon administration 2, 5
  • Patients should inform those around them about their condition and emergency treatment 4

Common Pitfalls to Avoid

  • Do NOT treat with protein-containing foods without adequate glucose as this can worsen hypoglycemia 1, 5
  • Do NOT fail to recheck blood glucose after initial treatment as this leads to recurrent hypoglycemia 5
  • Do NOT delay treatment as this can lead to severe outcomes including seizures and coma 2
  • Do NOT use sliding scale insulin as the sole insulin regimen as this is strongly discouraged 2
  • Do NOT skip meals when on premixed or fixed insulin regimens to reduce hypoglycemia risk 3

References

Guideline

Immediate Treatment of Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypoglycemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Managing Severe Hypoglycaemia in Patients with Diabetes: Current Challenges and Emerging Therapies.

Diabetes, metabolic syndrome and obesity : targets and therapy, 2023

Research

Hypoglycaemia in the diabetic child.

Bailliere's clinical endocrinology and metabolism, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.